CEMAG Consulting becomes CEMAG Care 

CEMAG CARE-1_RVB

Business & Mission

CEMAG Care mission is to answer patients’ medical needs

  • by developing and commercializing innovative medical devices and drugs
  • by allowing access of these treatments to populations in need

To achieve this mission, we foster innovative healthcare research projects into viable commercial products (drugs, medtech, biotech) and bring them to patients. Our motivation is to answer meaningful unmet medical need and bring to all patients the care they deserve.

Project-evaluation-blue

PHARMACEUTICAL OPERATIONS

Supplying diverse drugs to the European market

READ MORE
Product-development-blue

INNOVATIVE MEDICAL DEVICES

Development and commercialization of healthcare innovation:
Fostering the development and the commercialization of healthcare innovations such as medical devices or in vitro diagnostics

READ MORE
Market-strategy-blue

NON-FOR-PROFIT

Specific activity toward NFPO to facilitate medical product accessibility to population in need

READ MORE
Project-evaluation

PHARMACEUTICAL OPERATIONS

Pharmaceutical operations of various pharmaceutical products in France (“Exploitant Pharmaceutique”) and other European countries:

 

> Marketing and distribution of various pharmaceutical products in France (“Exploitant Pharmaceutique”) and other European countries

> Regulatory (submissions and applications and regulatory Life Cycle Management activities….)

> Pharmaceutical logistics

> Licensing and regulatory

> Medical Affairs (pharmacovigilance, medical information, clinical studies, scientific advice, Literature reviews, medical writing…)

> Service activities for third parties for regulatory strategy and registration in Europe

> A senior team with high expertise and a history of success stories

Product-development

INNOVATIVE MEDICAL DEVICES

> Product development in accordance with ISO13485: from initial patient needs to breakthrough medical solutions.

> Fostering our own projects of medical devices

> Providing service activities to help the development of innovative medical solutions (from Proof of Concept Studies to Market authorization

> Materiovigilance

> An expertized team focused on innovation for patients

Market-strategy

NON-FOR-PROFIT

> In healthcare, all patients are entitled to all approved products with the highest quality standards.

> Facilitating relationship between For-Profit Healthcare industry and Non-For-Profit Organizations, to allow :

          > Population in needs to access healthcare products
          > Healthcare companies to develop new market and increase their product volumes

> Supplier for Pharma industries dedicated to Non-For-Profit and Public markets (handling of tenders, agreement, logistics)

> Strong network with Non-For-Profit Organizations

our assets

Who we are

AREAS WHERE WE ARE CURRENTLY ACTIVE

  • null

    > Dermatology & Wound care

    > Tissue Engineering

    > Cellular & Gene Therapy

  • null

    > Women’s health

    > Fertility

  • null

    > Diagnostic

    > Prevention & Handicap

    > Training & loT

SOME PRIVILEGED PARTNERS

OUR NEWS


André Ulmann’s book

André Ulmann's book

March 2017

André Ulmann’s book « Le combat d’un médecin pour les femmes » has just been published (French edition only for the moment).

9791031202143

 


kdog

kdog

22/07/2016

CEMAG Consulting is very happy to further collaborate with Curie Institute regarding cancer detection (Kdog project)

news-kdog

fui project

FUI project

12/07/2016

CEMAG Consulting is part of the WISE Consortium led by Aryballe Technologies. The consortium received the support of bpifrance and Paris Region through FUI grant regarding a project on electronic nose.

news-fui

sme status

SME STATUS

15/04/2016

CEMAG Consulting is qualified as an SME by the EMA (SME Office)

news-sme